Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020
一项前瞻性、多中心上市后监测队列研究,旨在监测人乳头瘤病毒-16/18 AS04佐剂疫苗在中国9至45岁女性中的安全性(2018-2020年)。
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2283912
Wu, Qianhui; Qian, Mengcen; Welby, Sarah; Guignard, Adrienne; Rosillon, Dominique; Gopala, Kusuma; Xu, Yuan; Liu, Keruo; He, Yunkun; Jiang, Ning; Tan, Qin; Xie, Jiamin; Zhu, Taoying; Wang, Qizhang; Pan, Yingzi; Zeng, Ruikun; Yang, Jie; Zhao, Xiaoqian; Zhou, Man; Navarro-Torné, Adoración; Yu, Hongjie; Borys, Dorota